In Depth 30 Oct 2024
Spatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?
In Depth
- Latest Posts
In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
In Depth 25 Oct 2024
How biotech startups are trying to save the oceans with lab-grown fish
Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products.
In Depth 18 Oct 2024
The AI boom in cancer: Game-changer or just hype?
Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment.
In Depth 16 Oct 2024
JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer?
Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer.
In Depth 9 Oct 2024
Promising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease.
ADVERTISEMENT
ADVERTISEMENT
In Depth 8 Oct 2024
Top biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month.
In Depth 7 Oct 2024
Spinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.
In Depth 4 Oct 2024
The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.
In Depth 26 Sep 2024
The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond
Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.
In Depth 25 Sep 2024
How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market
Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.
In Depth 24 Sep 2024
New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster
Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development.
ADVERTISEMENT
